Mercury Laboratories Share Price

CMP as on27-May-22 15:59

₹ 490.00
29.5 6.41%

Open

₹ 490.50

Turnover (lac)

₹ 2

Prev. Close

₹ 460.50

Day's Vol (shares)

₹ 13

Day's Range

₹ 490.00
₹ 491.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 18-May-2022 - -
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 inter alia to consider and approve 1. Audited Financial Results of the Company for the quarter and year ended on March 31 2022 together with the Directors Report 2.recommendation of final dividend for the year ended on March 31 2022 if any subject to approval of shareholders at the ensuing AGM 3.To consider / decide date time and venue of AGM of the Members of the Company 4.Closure of the Register of Members and Share Transfer Books in connection with Annual General Meeting of the Company. 5. To consider and approve notice convening 41st AGM of the Members of the Company. 6. To consider re-appointment of Mr. Rajendra R Shah (DIN:00257253) as a Managing Director of the Company with effect from 1st April 2023 7.To consider an appointment of M/s Mitesh Rana & Co. Company Secretaries as Secretarial Auditor of the Company for the Financial Year 22-23 8.To consider an appointment of M/s. K R & Associates as an Internal Auditor of the Company for the FY 22-23 and any other items of Agenda if any Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2021-22 subject to approval of shareholders at an ensuing Annual General Meeting. (As Per BSE Announcement Dated on 26.05.2022)
Board Meeting - 21-Jan-2022 - -
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter ended on December 31 2021 2. take note of resignation of Ms. Kinjal Khandelwal as Company Secretary of the Company 3. Other Items of Agenda An Independent Directors meeting will be held on January 31 2022. Mercury Laboratories Limited-Outcome of Board Meeting held on January 31, 2022 An Independent Directors Meeting also held on January 31,2022 (As Per BSE Announcement Dated on 31.01.2022)
Board Meeting - 12-Oct-2021 - -
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve 1. Un-audited financial results of the Company for the quarter ended on September 30, 2021 2. To consider and approve appointment of Mr. Ashish Vasavada as Chief Financial Officer of the company with the effect from October 21, 2021. 3. To consider and approve any other items of Agenda, if any The results so approved will be published pursuant to provisions of LODR. Further, as per the Companys Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company shall remain closed till the completion of 48 hours after declaration of financial results at the Board Meeting for all the Directors/officers/Designated Persons of the Company & shall re-open from the start of the business hours on October 24, 2021. You are therefore requested to take the above information on records Mercury Laboratories Limited -Outcome of Board Meeting held on October 21, 2021 The Meeting was commenced at 05:00 P.m. and concluded at 07:00 P.m. Mercury Laboratories Limited-Financial Results for the Quarter/Half year ended September 30, 2021. (As per BSE Announcement Dated on 21/10/2021)
Board Meeting - 02-Aug-2021 - -
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve the Un-audited financial results of the Company for the quarter ended on June 30, 2021 along with other items of agenda if any. Further, as per the Companys Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, the trading window for dealing in the securities of the Company shall remain closed till the completion of 48 hours after declaration of financial results at the Board Meeting for all the Directors/officers/Designated Persons of the Company & shall re-open from the start of the business hours on August 13, 2021. All the Directors/Officers/Designated Persons of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window. You are therefore requested to take the above information on records and disseminate information to stakeholders of the Company. Mercury Laboratories Limited -Outcome of Board Meeting held on August 10, 2021 The Meeting was commenced at 05:00 P.m. and concluded at 07:15 P.m. Mercury Laboratories Limited-Financial Results for the year ended June 30, 2021 (As per BSE Announcement Dated on 10/8/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity